CompletedNot Applicable

Practice of Deep Venous Thrombosis Prophylaxis and Its Incidence in Patients Undergoing Gastrointestinal and Hepatobiliary Surgery

Nepal1,530 participantsStarted 2024-05-23

Plain-language summary

Recent studies from Asia have reported a wide variation in the incidence of deep vein thrombosis (DVT), ranging from 5% to 50% in patients undergoing major abdominal surgery. However, data specific to the Nepalese population remains unavailable. This study aims to evaluate current thromboprophylaxis practices and determine the incidence of DVT in Nepalese adults undergoing gastrointestinal and hepatobiliary surgery.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged \>18 years * Underwent major gastrointestinal or hepatobiliary surgery * Surgery performed under general anesthesia * Major surgery defined as any operative intervention in the abdominal or hepatobiliary region requiring general anesthesia Exclusion Criteria: * History of VTE within 3 months before surgery * Known hypercoagulable state or congenital thrombophilia * Diagnosis of atrial fibrillation * Undergoing systemic cancer chemotherapy or radiotherapy within the past 15 days * Pregnant or lactating women * Missing information in clinical records * Non-operated patients or those receiving conservative management * Patients undergoing liver transplantation

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Use of Thromboprophylaxis and Incidence of DVT in Major GI and Hepatobiliary Surgeries

Timeframe: From date of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first

Trial details

NCT IDNCT07088575

SponsorMaharajgunj Medical Campus

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-07-21

View on ClinicalTrials.gov More Gastrointestinal trials